Ignite Creation Date:
2024-05-06 @ 1:09 PM
Last Modification Date:
2024-10-26 @ 1:09 PM
Study NCT ID:
NCT03942094
Status:
UNKNOWN
Last Update Posted:
2022-03-16
First Post:
2019-05-06
Brief Title:
Nilotinib for First-line Newly Diagnosed CML-CP Patients
Sponsor:
Shenzhen Second Peoples Hospital
Organization:
Shenzhen Second Peoples Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Nilotinib |
| Chronic Myeloid Leukemia Chronic Phase |
Keywords:
| Name | View |
|---|---|
| Nilotinib | View |